MarginsXMarginsX
Home › Markets › Health Care › SION

Sionna Therapeutics Inc. (SION)

SION trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$3.12
-6.31% on the day
Market cap
$141.1M
Micro cap
Revenue
Recent IPO: no annual report filed yet
Net income
Recent IPO: no annual report filed yet

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerSION on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2025
SEC CIK0002036042
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

Recent IPO: no annual report filed yet.

Warning signs

Cash runway
12.7 months
$83.9M cash at September 30, 2026
Share count, 1 year
+1.4%
2025-10-31 to 2026-10-30
Going-concern doubt
No
10-Q filed November 10, 2026
Insider net buying, 12 months
-$134.3M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.
"The Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that these condensed consolidated financial statements are issued."
10-Q 2026-11-10
Cash and burn$83.9M cash; operating cash flow -$19.9M a quarter.Report 2026-09-30
Shares outstanding45,235,568 (2026-10-30); 44,628,788 a year earlier.Cover page 2026-10-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-03-02
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte & Touche LLP, Boston, Massachusetts, United StatesPCAOB Form AP 2026-03-06
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $134.3M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed-$32.4M-$18.7M$83.9MNo debt tagsNeeds four quarters10-Q 2026-11-10
Q2 2026
2026-06-30
Not filed-$29.9M-$22.2M$63.3MNo debt tagsNeeds four quarters10-Q 2026-11-10
Q1 2026
2026-03-31
Not filed-$26.8M-$21.8M$63.3MNo debt tagsNeeds four quarters10-Q 2026-11-10
Q4 2025
2025-12-31
Not filed-$20.4M-$16.6M$58.5MNo debt tagsNeeds four quarters10-K 2026-03-02
Q3 2025
2025-09-30
Not filed-$20.3M-$15.2M$50.8MNo debt tagsNeeds four quarters10-Q 2026-11-10
Q2 2025
2025-06-30
Not filed-$18.1M-$18.2M$41.0MNo debt tagsNeeds four quarters10-Q 2026-11-10
Q1 2025
2025-03-31
Not filed-$16.5M-$16.3M$82.7MNo debt tagsNeeds four quarters10-Q 2026-11-10
Q4 2024
2024-12-31
Not filed-$15.8M-$11.8M$37.8MNo debt tagsNeeds four quarters10-K 2026-03-02

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2026-03-02
Latest annual report10-K2026-03-02
Latest quarterly / interim10-Q2026-11-10
Latest current report8-K2026-11-10
Latest proxyDEFA14A2026-04-27

Source: SEC EDGAR submissions feed, 234 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+1.5%
1 month-24.0%
3 months-49.1%
Year to date-91.9%
1 year-90.7%
From 52-week high-93.5%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
RNAAtrium Therapeutics Inc.$6.43-14.38%$138.7M
MGNXMacroGenics Inc.$2.17-1.36%$138.7M
MSLESatellos Bioscience Inc.$6.47-2.34%$137.3M
VRXAVeraxa Biotech AG$1.04-5.86%$147.8M
MENSJyong Biotech Ltd.$1.77+0.57%$134.6M
ABEOAbeona Therapeutics Inc.$2.60+7.44%$148.6M
NTHINeOnc Technologies Holdings Inc.$4.54-7.54%$131.0M
CNTNCanton Strategic Holdings Inc.$1.64-4.09%$130.7M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier